BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33846395)

  • 1. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
    Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
    Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
    Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
    Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.
    Wen Q; Zhan Y; Zheng H; Zang H; Luo J; Zhang Y; Wang W; Feng J; Lu J; Chen L; Fan S
    Diagn Pathol; 2019 Oct; 14(1):108. PubMed ID: 31601252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer.
    Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Tabiev RM; Mochalnikova VV; Gratchev A
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma.
    Matsubara E; Komohara Y; Shinchi Y; Mito R; Fujiwara Y; Ikeda K; Shima T; Shimoda M; Kanai Y; Sakagami T; Suzuki M
    Pathol Int; 2021 Oct; 71(10):666-673. PubMed ID: 34231937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
    Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
    Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
    Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
    BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
    Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
    Ma H; Wang L; Zhang T; Shen H; Du J
    Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
    Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.
    Zhou H; Chen JH; Hu J; Luo YZ; Li F; Xiao L; Zhong MZ
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):633-43. PubMed ID: 24549739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro.
    Vattai A; Ziegelmüller B; Kost B; Kuhn C; Hofmann S; Bayer B; Anslinger K; Jeschke U; Ditsch N
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():31-39. PubMed ID: 26476797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
    Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
    BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.
    Kerr KM; Thunnissen E; Dafni U; Finn SP; Bubendorf L; Soltermann A; Verbeken E; Biernat W; Warth A; Marchetti A; Speel EM; Pokharel S; Quinn AM; Monkhorst K; Navarro A; Madsen LB; Radonic T; Wilson J; De Luca G; Gray SG; Cheney R; Savic S; Martorell M; Muley T; Baas P; Meldgaard P; Blackhall F; Dingemans AM; Dziadziuszko R; Vansteenkiste J; Weder W; Polydoropoulou V; Geiger T; Kammler R; Peters S; Stahel R;
    Lung Cancer; 2019 May; 131():95-103. PubMed ID: 31027705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.
    Elliott MJ; Jerzak KJ; Cockburn JG; Safikhani Z; Gwynne WD; Hassell JA; Bane A; Silvester J; Thu KL; Haibe-Kains B; Mak TW; Cescon DW
    Sci Rep; 2018 Nov; 8(1):16562. PubMed ID: 30410118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer.
    Li XB; Yang Y; Zhang HQ; Yue WT; Zhang TM; Lu BH; Li J; Liu Z; Wang QH; Gao Y; Hu AM; Zhang HM; Shi HL; Hu FB; Li BL
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2231-9. PubMed ID: 26166648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
    Pajares MJ; Agorreta J; Larrayoz M; Vesin A; Ezponda T; Zudaire I; Torre W; Lozano MD; Brambilla E; Brambilla C; Wistuba II; Behrens C; Timsit JF; Pio R; Field JK; Montuenga LM
    J Clin Oncol; 2012 Apr; 30(10):1129-36. PubMed ID: 22355056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.